OTCMJAPAY
Market cap47bUSD
Dec 20, Last price
13.20USD
1D
-0.15%
1Q
-7.69%
Jan 2017
-19.19%
Name
Japan Tobacco Inc
Chart & Performance
Profile
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, prescription drugs, and processed foods in Japan and internationally. The company operates through four segments: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, cigars, pipe tobacco, oral tobacco, waterpipe tobacco, kretek, and fine cut products under the Winston, Camel, MEVIUS, and LD brands. The company also provides reduced-risk products, including tobacco-infused vapor and heated tobacco products, E-Vapor products, etc. under the Ploom, Logic, Ploom TECH, Ploom TECH+, and Ploom S brands. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, renal and metabolism, immunology, and neuroscience. Further, the company provides staple food products, such as frozen noodles and okonomiyaki, and frozen and packed cooked rice; ambient processed foods; bakery products; and seasonings, including yeast extracts and oyster sauce. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 2,841,077,000 6.89% | 2,657,832,000 14.32% | 2,324,838,000 11.10% | |||||||
Cost of revenue | 2,080,461,000 | 2,336,708,000 | 2,115,288,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 760,616,000 | 321,124,000 | 209,550,000 | |||||||
NOPBT Margin | 26.77% | 12.08% | 9.01% | |||||||
Operating Taxes | 136,292,000 | 149,277,000 | 132,208,000 | |||||||
Tax Rate | 17.92% | 46.49% | 63.09% | |||||||
NOPAT | 624,324,000 | 171,847,000 | 77,342,000 | |||||||
Net income | 482,289,000 8.94% | 442,716,000 30.79% | 338,490,000 9.10% | |||||||
Dividends | (367,331,000) | (266,175,000) | (251,935,000) | |||||||
Dividend yield | 5.68% | 5.63% | 6.11% | |||||||
Proceeds from repurchase of equity | (1,000) | (1,000) | 59,108,000 | |||||||
BB yield | 0.00% | 0.00% | -1.43% | |||||||
Debt | ||||||||||
Debt current | 233,333,000 | 137,308,000 | 142,901,000 | |||||||
Long-term debt | 946,715,000 | 861,010,000 | 817,811,000 | |||||||
Deferred revenue | 362,928,000 | |||||||||
Other long-term liabilities | 492,817,000 | 507,589,000 | 179,194,000 | |||||||
Net debt | (82,538,000) | (65,876,000) | 88,602,000 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 567,014,000 | 483,799,000 | 598,909,000 | |||||||
CAPEX | (94,861,000) | (99,408,000) | (102,918,000) | |||||||
Cash from investing activities | (126,129,000) | (101,822,000) | (97,499,000) | |||||||
Cash from financing activities | (270,500,000) | (306,176,000) | (353,138,000) | |||||||
FCF | 417,396,000 | (17,061,000) | 119,833,000 | |||||||
Balance | ||||||||||
Cash | 1,040,206,000 | 904,562,000 | 738,985,000 | |||||||
Long term investments | 222,380,000 | 159,632,000 | 133,125,000 | |||||||
Excess cash | 1,120,532,150 | 931,302,400 | 755,868,100 | |||||||
Stockholders' equity | 3,665,208,000 | 3,370,544,000 | 3,040,666,000 | |||||||
Invested Capital | 4,427,035,850 | 4,113,888,600 | 3,560,162,900 | |||||||
ROIC | 14.62% | 4.48% | 2.19% | |||||||
ROCE | 13.61% | 6.31% | 4.78% | |||||||
EV | ||||||||||
Common stock shares outstanding | 1,775,557 | 1,775,383 | 1,775,161 | |||||||
Price | 3,645.00 36.98% | 2,661.00 14.57% | 2,322.50 10.49% | |||||||
Market cap | 6,471,905,265 36.99% | 4,724,294,163 14.59% | 4,122,811,422 10.50% | |||||||
EV | 6,471,703,265 | 4,734,744,163 | 4,688,322,422 | |||||||
EBITDA | 940,268,000 | 520,775,000 | 396,607,000 | |||||||
EV/EBITDA | 6.88 | 9.09 | 11.82 | |||||||
Interest | 95,222,000 | 91,272,000 | 45,645,000 | |||||||
Interest/NOPBT | 12.52% | 28.42% | 21.78% |